Keywords: پادگن مخصوص پروستات; AG-I; type I arabinogalactan; AG-II; type II arabinogalactan; ASGP-R; asialoglycoprotein receptor; CP; citrus pectin; CRD; carbohydrate recognition domain; CSDDS; colon-specific drug delivery system; DF; dietary fiber; DM; degree of methylation; DR; death
مقالات ISI پادگن مخصوص پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پادگن مخصوص پروستات; Digital multimeter; Enzyme immunoassay; Prostate-specific antigen; Glucose oxidase
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Prostatic neoplasms; Biopsy; Needles
Keywords: پادگن مخصوص پروستات; prostate; prostate-specific antigen; cryosurgery; disease progression; mortality; ASTRO; American Society for Therapeutic Radiology and Oncology; BPFS; biochemical progression-free survival; COLD; Cryo On-Line Database; PSA; prostate specific antigen;
Keywords: پادگن مخصوص پروستات; PSA, prostate-specific antigen; CT, computed tomography; MRI, magnetic resonance imaging; MDP, methylene diphosphonate; H&E, hematoxylin–eosinMetastatic prostate adenocarcinoma; Mandible; Prostate-specific antigen
Keywords: پادگن مخصوص پروستات; Prostatic neoplasms; Pathology; Prostate-specific antigen; Tumor burden;
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; body mass index; risk factors; neoplasm gradingAA, African-American; BMI, body mass index; bmiPCPTRC, BMI adjusted Prostate Cancer Prevention Trial prostate cancer risk calculator; DRE, digital rectal examin
Keywords: پادگن مخصوص پروستات; prostate-specific antigen; ancillary services; hospital; jurisprudence; urology; physicians; primary care; IOAS; in-office ancillary services; NAMCS; National Ambulatory Medical Care Survey; PCP; primary care physician; PSA; prostate specific antigen;
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; n-3 polyunsaturated fatty acids; Epidemiology
Keywords: پادگن مخصوص پروستات; TST, testosterone supplementation therapy; CaP, prostate cancer; DHT, 5α-dihydrotestosterone; PSA, prostate specific antigenTestosterone; Hypogonadism; Androgens; Prostate cancer; Saturation; Prostate-specific antigen
Keywords: پادگن مخصوص پروستات; Prostate cancer; Mass screening; Clinical trials; Prostate-specific antigen; Simulation modeling; Public health policy;
Keywords: پادگن مخصوص پروستات; prostate; prostatic neoplasms; prostate-specific antigen; mass screening; practice guidelines as topic; ACP; American College of Physicians; AUA; American Urological Association; PCP; primary care physician; PSA; prostate specific antigen; USPSTF; United
Keywords: پادگن مخصوص پروستات; Prostate cancer; Localized; Screening; Prostate-specific antigen; United States Preventive Services Task Force;
Keywords: پادگن مخصوص پروستات; Competitive-type displacement reaction; Nanogold-labeled antibody; Prostate-specific antigen; Potentiometric immunoassay; Polyethyleneimine-poly(styrene-co-acrylic acid) microsphere
Keywords: پادگن مخصوص پروستات; Proximity ligation assay; Prostate-specific antigen; Mutant p53 detection;
Keywords: پادگن مخصوص پروستات; Prostate neoplasms; Prostate-specific antigen; Early detection of cancer
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Diagnosis; Gleason score
Keywords: پادگن مخصوص پروستات; Transurethral resection of prostate; Prostate-specific antigen; Prostate neoplasms
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; African Americans; AfricaDRE, digital rectal examination; fPSA, free PSA; PSA, prostate specific antigen; PSAD, PSA density; TRUS, transrectal ultrasound
Keywords: پادگن مخصوص پروستات; Prostatic neoplasms; Prostatectomy; Prostate-specific antigen; Neoplasm recurrence; Local; Salvage therapy; Radiotherapy; Adjuvant; Models; Statistical
Keywords: پادگن مخصوص پروستات; prostate; neoplasm recurrence; local; prostatectomy; prostate-specific antigen; prognosisADT, androgen deprivation therapy; BCR, biochemical recurrence; LD, low detectable; NCCN®, National Comprehensive Cancer Network®; ORP, open retropubic RP; PSA, prost
Keywords: پادگن مخصوص پروستات; Bisphosphonates; Bone metastasis; Castration-resistant prostate cancer; Prostate-specific antigen; PSA kinetics; Skeletal complications; Zoledronic acid
Keywords: پادگن مخصوص پروستات; Prostate cancer; Androgen-deprivation therapy; Prostate-specific antigen;
Keywords: پادگن مخصوص پروستات; Castration resistant prostate cancer; Cabazitaxel; Prostate-specific antigen; Chemotherapy; Cytotoxic agents; Survival rate;
Keywords: پادگن مخصوص پروستات; prostate; prostatic neoplasms; magnetic resonance imaging; prostate-specific antigen; mass screeningDCEI, dynamic contrast enhanced imaging; DRE, digital rectal examination; DWI, diffusion-weighted imaging; ESUR, European Society of Urogenital Radiology;
Keywords: پادگن مخصوص پروستات; Biopsy; Contamination; PALGA; Prostatic neoplasms; Prostate-specific antigen; Nonattendance; Screening
Keywords: پادگن مخصوص پروستات; prostate; prostatic neoplasms; prostate-specific antigen; biopsy; riskAS, active surveillance; NPV, negative predictive value; PPV, positive predictive value; PSA, prostate specific antigen; PSAD, PSA density; PSAV, PSA velocity; RC, risk count
Keywords: پادگن مخصوص پروستات; Prostate cancer; Biomarkers; Prostate-specific antigen; Prostate cancer antigen 3
Keywords: پادگن مخصوص پروستات; Testosterone; Androgens; Prostate cancer; Saturation; Prostate-specific antigen
Keywords: پادگن مخصوص پروستات; BPH; benign prostatic hyperplasia; PSA; prostate-specific antigen; US; ultrasound;
Keywords: پادگن مخصوص پروستات; AI; aromatase inhibitor; AR; androgen receptor; ARE; androgen-response element; DDC; l-DOPA decarboxylase; DHT; dihydrotestosterone; ER; estrogen receptor α; ERE; estrogen-response element; E2; estradiol; GFP; green fluorescent protein; LI; labeling inde
Keywords: پادگن مخصوص پروستات; Access to care; African American; Cancer detection; Cancer screening; Prostate cancer; Prostate-specific antigen; Racial disparities;
Keywords: پادگن مخصوص پروستات; DEHP; di-2-ethylhexyl phthalate; DiNP; diisononyl phthalate; MEHP; mono-2-ethylhexyl phthalate; MiNP; monoisononyl phthalate; 5OH-MEHP; 2-ethyl-5-hydroxy-hexyl phthalate; 5oxo-MEHP; 2-ethyl-5-oxyhexyl phthalate; 5cx-MEPP; 5-carboxy-mono-2-ethylpenty phtha
Keywords: پادگن مخصوص پروستات; Prostate cancer; Magnetic resonance imaging; Fusion biopsy; Targeted prostate biopsy; Prostate-specific antigen; Ultrasonography; Transrectal ultrasonography;
Keywords: پادگن مخصوص پروستات; 2DE; two dimensional electrophoresis; AKI; acute kidney injury; ANN; artificial neural networks; ATN; acute tubular necrosis; BPN; brain natriuretic peptide; CAD; coronary artery disease; CE-MS; capillary electrophoresis coupled to mass spectrometry; CK
Keywords: پادگن مخصوص پروستات; Screening; Prostate cancer; Prostate-specific antigen; PSA; Digital rectal examination; DRE;
Keywords: پادگن مخصوص پروستات; ABEI; N-(4-aminobutyl)-N-ethylisoluminol; Ab; Antibody; ADM; Adriamycin; AFP; Alpha fetoprotein; Ag; Antigen; ALP; Alkaline phosphatase; ATP; Adenosine triphosphate; bbc-DL-DNA; bio-bar-code dendrimer-like DNA; BPE; Biophoton emission; CA; Carcinoma antig
Keywords: پادگن مخصوص پروستات; Immunosensor; Prostate-specific antigen; Mesoporous silica nanoparticles; Silver nanoparticles; Hydroquinone;
Keywords: پادگن مخصوص پروستات; Prostate-specific antigen; Classification and regression tree analysis; Entropy; Prostate cancer; Information theory;
Keywords: پادگن مخصوص پروستات; External beam radiation therapy; Brachytherapy; Prostate-specific antigen; Biochemical control; Overall survival; Toxicity; Outcomes; Prostate cancer;
Keywords: پادگن مخصوص پروستات; BRFSS; Behavioral Risk Factor Surveillance System; CTR; Connecticut Tumor Registry; EXP; expected; NCI; National Cancer Institute; OBS; observed; PSA; Prostate-Specific Antigen; RR; relative rate/risk; SEER; Surveillance Epidemiology and End Results; Pros
Keywords: پادگن مخصوص پروستات; prostate; prostatic neoplasms; prostatectomy; prostate-specific antigen; pathology, surgical; BCR; biochemical recurrence; PSA; prostate specific antigen; PSM; positive surgical margin; RP; radical prostatectomy; TBCR; time to BCR;
Keywords: پادگن مخصوص پروستات; APM; antigen processing machinery; BMI; body mass index; CTLs; cytotoxic T-cells; DC; dendritic cells; DCA; dichloroacetate; ERK; extracellular signal-regulated kinases; GTN; glyceryl trinitrate; HAT; histone acetyltransferases; HLA; human leukocyte antig
Keywords: پادگن مخصوص پروستات; Cancer prevention; Cancer burden; Risk factors; Epidemiology; COPD; chronic obstructive pulmonary disease; HDI; Human Development Index; HBV; hepatitis B virus; HCV; hepatitis C virus; H. pylori; Helicobacter pylori; HPV; human papillomavirus; IARC; Inter
Keywords: پادگن مخصوص پروستات; prostate; prostate-specific antigen; prostatic neoplasms
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; testosterone; risk assessment; prostate-specific antigen; neoplasm recurrence, localADT, androgen deprivation therapy; AS, active surveillance; BCR, biochemical recurrence; CaP, prostate cancer; EBRT, external beam radiation therapy;
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; biopsy; prostate-specific antigen; watchful waiting; complicationsAS, active surveillance; CaP, prostate cancer; FCO, for-cause only; PSA, prostate specific antigen; RPCI, Roswell Park Cancer Institute; S+FC, scheduled and for-cause
Keywords: پادگن مخصوص پروستات; Sperm Hy-Liter™ PI; Sexual assault; DNA; Semenogelin; Prostate-specific antigen
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results
Keywords: پادگن مخصوص پروستات; prostatic neoplasms; prostate-specific antigen; MDV 3100; bone density; drug related side effects and adverse reactions; ADT; androgen deprivation therapy; AE; adverse event; bALP; bone alkaline phosphate; BMD; bone mineral density; CR; complete response;
Disposable aptasensor combining functional magnetic nanoparticles with rolling circle amplification for the detection of prostate-specific antigen
Keywords: پادگن مخصوص پروستات; Aptasensor; Prostate-specific antigen; Rolling circle amplification; Functional magnetic nanoparticles;